Neal J. Sandy

The Hattie Larlham Center for Children with Disabilities (HLCCD) is home to 126 children and young adults with developmental disabilities and medically fragile conditions it is located in 27 acres. The home-like environment at the HLCCD promotes interaction with peers and family members. Comfortable, quiet areas allow families to visit with loved ones without feeling rushed or in the way of daily operations. Large, open recreation spaces bring individuals, families and friends together for activities. The organisation was founded in 1963 and is headquartered in Mantua, OH.

Decisio Health, Inc. provides clinical surveillance visualization system. Its solutions include population surveillance, analytics dashboard, virtual care/telehealth, and point of care monitoring. The company was founded by John Holcomb, Gray Hancock, and Bryan Haardt in 2013 and is headquartered in Houston, TX.

Cellectar, Inc. is a clinical stage radiopharmaceutical company that designs and develops products to detect, treat and monitor a wide variety of human cancers. Cellectar began independent lab activities in February 2003 after forming a company and raising initial funds in the 2000-2002 timeframe. Its product candidates combine phospholipids ethers analogs (PLEs), which are lipid-like molecules, with radioisotopes that destroy or image malignant cancer cells. Because only malignant tumor cells and tissues retain large amounts of these compounds, malignant cancer-selective retention of therapeutic or diagnostic doses of radioactivity can be achieved. Cellectar has demonstrated specific uptake and retention of its product candidates in more than 45 tumor types tested in proof-of-principle preclinical animal studies. In addition, ten preclinical experiments have shown anti-tumor activity in each tumor type studied including breast, prostate, lung, glioma, pancreatic, melanoma, ovarian, uterine, renal and colorectal cancers. The compound, originally known as NM404, is being taken through the regulatory process as CLR1404. Capitalizing on the unique characteristics of malignant cancer cells, Cellectar's molecules will be designed to find, treat and follow malignancies through the delivery of radiopharmaceuticals in a novel, highly selective way.

Nicolet Biomedical, Inc. manufactures and distributes medical instrumentation systems. The firm provides products for neurophysiologic diagnosis and monitoring systems for the brain, muscles and respiratory system. The company is headquartered in Madison, WI.

Part of General Electric Co., GE Healthcare Finland Oy is a Finnish company that manufactures and markets medical imaging, information technologies, medical diagnostics and patient monitoring systems. The company is based in Helsinki, Finland.

GE Healthcare Ltd. provides transformational medical technologies and services which include icenter, AssetPlus, preventive maintenance, continuity, digital solutions and Unisys multi brand probe repair services. The firm offers magnetic resonance imaging, hemodynamic recording, EP recording, metabolic health and computed tomography. The company was founded on February 16, 1971 and is headquartered in Little Chalfont, the United Kingdom.